Category

HIV/AIDS

HIV Vaccines Could Vastly Improve HIV Prevention – And You Can Help

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
There were a reported 2.1 million new HIV infections in 2015, and 36.7 million people are currently living with HIV/AIDS globally. Vaccines could be an incredibly powerful tool in the fight against HIV/AIDS, with the potential to dramatically reduce the number of new HIV infections around the world. In continuation of Fenway Health’s decades-long commitment to treating and preventing HIV/AIDS, The Fenway Institute is excited to serve as a study site for several HIV vaccine trials, including HVTN 108. HVTN 108 will examine both tolerability of a new HIV vaccine and the immune system’s response to it. It’s important to 
Read More

The American Health Care Act Would Harm LGBT People, People Living With HIV, And Black And Latino Americans, According To Fenway Institute Analysis

By | Fenway Health Newsroom, Health Care, Health Policy, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
The Fenway Institute of Fenway Health released a policy brief outlining how the American Health Care Act (AHCA), the Trump Administration’s proposed replacement for the Affordable Care Act (ACA), could impact LGBT people, people living with HIV (PLWH), and Black and Latino Americans. “This bill holds potentially devastating consequences for low-income LGBT people, people living with HIV, and Black and Latino people” said Sean Cahill, PhD, Director of Policy Research for The Fenway Institute at Fenway Health. “The rates of uninsurance among LGBT people and people living with HIV have dropped dramatically since 2013, when the Affordable Care Act’s Medicaid 
Read More

Policy Changes May Expand Behavioral Health Care Access For People Living With HIV/AIDS

By | Behavioral Health, Fenway Health Newsroom, Health Policy, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Comprehensive behavioral health care is a key component of overall wellness. For people living with HIV (PLWH), access to these services is especially critical. The stress caused by pervasive stigma and discrimination around HIV/AIDS has been shown to contribute to a number of behavioral health problems, including depression, anxiety, psychological trauma, and substance abuse. The duel challenges of HIV and psychiatric diagnoses means that this population has unique behavioral health needs that must be integrated into culturally-competent care plans. A new brief from The National Center for Innovation in HIV Care at The Fenway Institute outlines recent changes in federal 
Read More

LGBT People And Those Living With HIV Have Benefitted From ACA, Have Much At Stake In Reform Debate

By | Fenway Health Newsroom, Health Policy, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
Today, The Fenway Institute of Fenway Health released a policy brief outlining the essential elements of a revised national health insurance strategy to ensure that LGBT people and people living with HIV have broad access to health insurance and culturally competent care. LGBT people and people living with HIV have disproportionately benefitted from the Affordable Care Act’s expansion of health insurance coverage. “As Congress and the Trump Administration debate what will be included in a new, national health care insurance plan, it will be important to include provisions that ensure broad access to health care insurance for LGBT people and 
Read More

Help Shape The Future Of HIV Prevention: Join A Research Study Today

By | HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
The battle against HIV/AIDS has shifted dramatically in the past decade, as our understanding of the virus and how to combat it has increased. The introduction of Pre-Exposure Prophylaxis (PrEP), a daily pill commonly known as Truvada, has been an incredible game changer for HIV prevention. Currently, condom use and PrEP are the most proven effective methods for protection against HIV infection. “Using Truvada for PrEP has been revolutionary for HIV prevention, but, unfortunately, it’s not a one size fits all solution,” said Ryan Tappin, Clinical Manager, Biomedical Research at The Fenway Institute. “The more choices for PrEP that patients 
Read More